Actavis Labs Fl Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ACTAVIS LABS FL, and what generic and branded alternatives to ACTAVIS LABS FL drugs are available?
ACTAVIS LABS FL has eighty approved drugs.
There are seven tentative approvals on ACTAVIS LABS FL drugs.
Drugs and US Patents for Actavis Labs Fl
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Actavis Labs Fl Inc | AMPHETAMINE | amphetamine | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL | 209253-001 | Jun 22, 2023 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Actavis Labs Fl Inc | FENTANYL CITRATE | fentanyl citrate | TABLET;SUBLINGUAL | 207338-002 | Nov 17, 2017 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Actavis Labs Fl | MESALAMINE | mesalamine | TABLET, DELAYED RELEASE;ORAL | 203817-001 | Mar 23, 2018 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Actavis Labs Fl Inc | CYCLOBENZAPRINE HYDROCHLORIDE | cyclobenzaprine hydrochloride | TABLET;ORAL | 071611-002 | Feb 3, 2006 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for ACTAVIS LABS FL drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Here is a list of applicants with similar names.